Enterprise NHP Strategy and Governance Lead

Novartis • Cambridge, MA

6d • $168,000 - $312,000 • Hybrid

About The Position

As the Enterprise NHP Strategy & Governance Lead you will be accountable for defining, governing, and operationalizing Novartis’ enterprise wide strategy for the ethical, scientifically justified, and operationally resilient use of non human primates (NHPs) in preclinical research. You will lead cross functional governance, portfolio forecasting, supply chain resilience, and external positioning to ensure regulatory alignment, scientific rigor, and measurable reduction in NHP use through NAMs and advanced alternatives.

Requirements

• Board-certified laboratory animal veterinarian (Dip ACLAM) with 10 or more years of experience in biomedical research involving nonhuman primates
• Deep experience in preclinical research strategy, operations, or translational science
• Proven leadership in enterprise governance and cross‑functional alignment in a complex, matrixed pharmaceutical R&D environment
• Strong understanding of NHP ethics, regulation, and animal welfare frameworks including application of the 3Rs, and integration of NAMs and advanced alternatives
• Experience with portfolio forecasting, capacity planning, and scenario modeling
• Credibility with Health Authorities, external partners, and scientific consortiums
• Demonstrated ability to drive alignment and behavior change across scientific, operational, and animal welfare stakeholders without direct line authority

Responsibilities

• Establish and lead an enterprise‑wide NHP governance model, including a cross‑functional council spanning PCS, PKS, SciOps, Animal Welfare, Procurement, and NBR Disease Areas.
• Define and enforce enterprise decision principles for NHP use, including prioritization, scientific justification, study placement, and supply allocation.
• Drive a structured governance cadence (e.g., steering committees, portfolio alignment) to ensure timely, aligned decision‑making.
• Own enterprise visibility and escalation mechanisms, including dashboards and global escalation frameworks for supply constraints, CRO quality issues, and portfolio conflicts.
• Partner with operations teams to ensure NHP supply continuity, optimizing BCUS and global colony capacity and utilization.
• Strengthen supplier and CRO performance, including long‑term sourcing strategies, CRO oversight standards, and quality KPIs.
• Lead alignment of global and regional NHP strategies, including China‑specific sourcing, logistics, feasibility, and regulatory considerations.
• Build and own a multi-year enterprise NHP forecasting and scenario-planning capability, aligned to modality mix, portfolio priorities, and clinical timelines.
• Integrate NHP planning with financial and resource planning, ensuring transparency of cost drivers and reserve strategies.
• Represent and position Novartis as an industry leader in ethical, science‑driven NHP use through Health Authority engagement, external collaborations, and enterprise communications.

Benefits

• US-based eligible employees will receive a comprehensive benefits package that includes health, life and disability benefits, a 401(k) with company contribution and match, and a variety of other benefits.
• In addition, employees are eligible for a generous time off package including vacation, personal days, holidays and other leaves.

What This Job Offers

• Job Type: Full-time
• Career Level: Director
• Education Level: No Education Listed